OrganiGram Holdings Operating Expenses 2011-2026 | OGI

Annual Operating Expenses OrganiGram Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	41.4 M	42.4 M	16.1 M	8.04 M	4.07 M	9.35 M	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
42.4 M	4.07 M	20.2 M

Operating Expenses of other stocks in the Drug manufacturers industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	40.3 M	-	7.5 %	$ 6.35 M	USA
Alimera Sciences ALIM	71.8 M	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	213 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	30.5 M	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	38.9 M	-	0.86 %	$ 117 M	USA
Canopy Growth Corporation CGC	197 M	$ 0.97	2.36 %	$ 104 M	Canada
Aurora Cannabis ACB	183 M	$ 3.31	1.53 %	$ 86.3 M	Canada
China Pharma Holdings CPHI	2.6 M	$ 0.63	16.11 %	$ 11 M	China
Catalent CTLT	512 M	-	-	$ 11.5 B	USA
Athenex ATNX	96.7 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	196 M	-	-	$ 2.06 B	France
Cronos Group CRON	154 M	$ 2.52	5.44 %	$ 1.31 B	Canada
DURECT Corporation DRRX	44.6 M	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	558 M	$ 8.05	-1.71 %	$ 412 M	USA
Endo International plc ENDP	763 M	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	12.6 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	213 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	106 M	-	2.45 %	$ 38.1 M	Canada
Cumberland Pharmaceuticals CPIX	35.2 M	$ 3.05	7.77 %	$ 42.9 M	USA
Bausch Health Companies BHC	4.96 B	$ 5.1	1.8 %	$ 1.86 B	Canada
Harrow Health HROW	174 M	$ 34.0	2.16 %	$ 1.25 B	USA
Assertio Holdings ASRT	133 M	$ 14.0	4.71 %	$ 89.6 M	USA
OptiNose OPTN	129 M	-	-	$ 1.08 B	USA
Evolus EOLS	107 M	$ 4.68	0.86 %	$ 302 M	USA
Eagle Pharmaceuticals EGRX	113 M	-	-39.89 %	$ 27.7 M	USA
Pacira BioSciences PCRX	279 M	$ 22.65	2.44 %	$ 1.05 B	USA
PetIQ PETQ	138 M	-	1.64 %	$ 400 M	USA
PLx Pharma PLXP	44.2 M	-	-27.8 %	$ 2.56 M	USA
ProPhase Labs PRPH	47.1 M	-	-	$ 5.07 M	USA
Jupiter Wellness JUPW	39.6 M	-	-	$ 33.6 M	USA
Radius Health RDUS	304 M	-	-	$ 1.42 B	USA
Relmada Therapeutics RLMD	59.1 M	$ 5.86	-3.46 %	$ 231 M	USA
Rockwell Medical RMTI	31.1 M	$ 1.02	-2.86 %	$ 23.8 M	USA
Lannett Company LCI	209 M	-	1.15 %	$ 7.11 M	USA
Sundial Growers SNDL	102 K	$ 1.36	0.74 %	$ 3.37 M	Canada
SCYNEXIS SCYX	36.7 M	$ 0.88	-6.09 %	$ 43.9 M	USA
Solid Biosciences SLDB	179 M	$ 7.14	1.56 %	$ 625 M	USA
Organogenesis Holdings ORGO	368 M	$ 2.47	3.65 %	$ 325 M	USA
Neoleukin Therapeutics NLTX	55.6 M	-	-	$ 193 M	Canada
Perrigo Company plc PRGO	2.62 B	$ 9.57	3.46 %	$ 1.33 B	USA
Sonoma Pharmaceuticals SNOA	9.18 M	$ 2.55	4.94 %	$ 3.16 M	USA
Tilray TLRY	1.52 B	$ 6.45	3.86 %	$ 3.99 B	Canada
Recro Pharma REPH	22.5 M	-	-4.76 %	$ 65.3 M	USA
TherapeuticsMD TXMD	9.82 M	$ 2.31	3.12 %	$ 24.1 M	USA
Veru VERU	44 M	$ 2.3	1.32 %	$ 310 M	USA
Viatris VTRS	5.67 B	$ 13.29	0.68 %	$ 16 B	USA
cbdMD YCBD	28.9 M	$ 0.76	11.88 %	$ 3.28 M	USA
Tricida TCDA	153 M	-	-	$ 3.25 M	USA
Zynerba Pharmaceuticals ZYNE	35.3 M	-	-	$ 55.5 M	USA